Documents
Application Sponsors
ANDA 077802 | GLENMARK PHARMS LTD | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Application Products
001 | TABLET;ORAL | 150MG | 0 | OXCARBAZEPINE | OXCARBAZEPINE |
002 | TABLET;ORAL | 300MG | 0 | OXCARBAZEPINE | OXCARBAZEPINE |
003 | TABLET;ORAL | 600MG | 0 | OXCARBAZEPINE | OXCARBAZEPINE |
FDA Submissions
| ORIG | 1 | AP | 2007-10-09 | |
LABELING; Labeling | SUPPL | 2 | AP | 2010-06-29 | |
LABELING; Labeling | SUPPL | 4 | AP | 2011-12-28 | |
REMS; REMS | SUPPL | 5 | AP | 2012-01-19 | |
LABELING; Labeling | SUPPL | 8 | AP | 2015-01-20 | STANDARD |
LABELING; Labeling | SUPPL | 11 | AP | 2015-01-20 | STANDARD |
LABELING; Labeling | SUPPL | 13 | AP | 2020-08-25 | STANDARD |
LABELING; Labeling | SUPPL | 15 | AP | 2020-08-25 | STANDARD |
LABELING; Labeling | SUPPL | 17 | AP | 2020-08-25 | STANDARD |
Submissions Property Types
SUPPL | 2 | Null | 8 |
SUPPL | 4 | Null | 15 |
SUPPL | 5 | Null | 15 |
SUPPL | 8 | Null | 15 |
SUPPL | 11 | Null | 7 |
SUPPL | 13 | Null | 7 |
SUPPL | 15 | Null | 7 |
SUPPL | 17 | Null | 15 |
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
003 | Prescription | AB |
CDER Filings
GLENMARK PHARMS LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 77802
[companyName] => GLENMARK PHARMS LTD
[docInserts] => ["",""]
[products] => [{"drugName":"OXCARBAZEPINE","activeIngredients":"OXCARBAZEPINE","strength":"150MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"OXCARBAZEPINE","activeIngredients":"OXCARBAZEPINE","strength":"300MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"OXCARBAZEPINE","activeIngredients":"OXCARBAZEPINE","strength":"600MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"10\/09\/2007","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/077802s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"OXCARBAZEPINE","submission":"OXCARBAZEPINE","actionType":"150MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"OXCARBAZEPINE","submission":"OXCARBAZEPINE","actionType":"300MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"OXCARBAZEPINE","submission":"OXCARBAZEPINE","actionType":"600MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 2007-10-09
)
)